270 related articles for article (PubMed ID: 2687554)
1. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
2. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Klimt CR; Doub PH; Doub NH
Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
[TBL] [Abstract][Full Text] [Related]
3. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
4. Role of platelet-active drugs in coronary artery disease.
Sherry S
Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
[No Abstract] [Full Text] [Related]
5. Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Jafri SM
Henry Ford Hosp Med J; 1991; 39(3-4):195-9. PubMed ID: 1804824
[No Abstract] [Full Text] [Related]
6. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Verdecchia P
G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
[No Abstract] [Full Text] [Related]
7. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Castaldi PA
Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet inhibitor therapy in myocardial infarction.
Stein B; Fuster V
Cardiovasc Drugs Ther; 1989 Dec; 3(6):797-813. PubMed ID: 2487543
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives in the antiplatelet therapy of thrombotic disorders.
Breddin HK
Semin Thromb Hemost; 1989 Apr; 15(2):144-9. PubMed ID: 2665085
[No Abstract] [Full Text] [Related]
10. Secondary prevention of myocardial infarction--the present state of the ART.
Mitchell JR
Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
[No Abstract] [Full Text] [Related]
11. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
12. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
13. Aspirin and recurrent myocardial infarction.
Jones RJ
JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
[No Abstract] [Full Text] [Related]
14. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
15. Aspirin and dipyridamole and their limitations in the therapy of coronary artery disease.
Rowe GG; Folts JD
Clin Cardiol; 1990 Mar; 13(3):165-70. PubMed ID: 2182246
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
McNicol GP
Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
[No Abstract] [Full Text] [Related]
17. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Croveri G
Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
[No Abstract] [Full Text] [Related]
18. Effect of drugs of platelets and complications of vascular disease.
Mustard JF; Packham MA; Kinlough-Rathbone RL
Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
[No Abstract] [Full Text] [Related]
19. Platelets and antiplatelet therapy in ischemic heart disease.
Frishman WH; Miller KP
Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
[No Abstract] [Full Text] [Related]
20. [Present situation of therapy with platelet aggregation inhibitors].
Poliwoda H
Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
[No Abstract] [Full Text] [Related]
[Next] [New Search]